Perspectives on RAGE signaling and its role in cardiovascular disease

Am J Med Genet A. 2013 Nov;161A(11):2750-5. doi: 10.1002/ajmg.a.36181. Epub 2013 Oct 3.

Abstract

RAGE stands for Receptor of Advanced Glycation Endproducts. The two main topics discussed are (1) the nature of RAGE signaling and (2) its role in cardiovascular disease. RAGE may occur in membrane-bound form or in secretory form. RAGE signaling involves multiple ligands: (1) several AGEs (2) amyloid β pecursor protein (APP), (3) high mobility group box 1 (HMGB1), (4) S100A4, (5) S100A8/A9, and (6) S100A12, which are calcium-binding proteins, and (7) S100B, a glial-derived protein. RAGE ligands and various diseases involving RAGE signaling are summarized in tabular form.

Keywords: AGEs; Alzheimer disease; HMGB1; RAGE signaling; cancer; cardiovascular disease; diabetes mellitus; inflammation; ischemia-reperfusion injury to the heart; membrane-bound RAGE; renal disease; secretory RAGE.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / metabolism*
  • Gene Expression
  • Humans
  • Ligands
  • Receptor for Advanced Glycation End Products / genetics
  • Receptor for Advanced Glycation End Products / metabolism*
  • Signal Transduction*

Substances

  • Ligands
  • Receptor for Advanced Glycation End Products